You have 9 free searches left this month | for more free features.

Relapsing Multiple Sclerosis (2)

Completed (1)

Recruiting (1)

phase 2 (1)

Peking University Third Hospital (1)

Sanofi (1)

sar442168 (2)

locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (mri) (1)

placebo (1)

drug (2)

Industry (1)

Other (1)

Interventional (1)

Observational (1)

sar442168

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jul 6, 2021

Completed

Jan 19, 2021